Posaconazole Tablet, Delayed Release
Product Images NDC 73141-023

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 73141-023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A2a Integrated Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container-100mg (Container 100mg)

Label of Posaconazole Delayed-Release Tablets 100 mg by A2A Integrated Pharmaceuticals. The label states the NDC 73141-023-02, dosage form as delayed-release tablets, and package contains 60 tablets. Storage instructions are included along with a note that Noxafil oral suspension and delayed-release tablets are not interchangeable. The label features a barcode and distributor information in Bowling Green, KY.*

FDA Label Image

Structure (Structure.jpg)

Chemical structure of the active ingredient posaconazole, showing its complex molecular arrangement with multiple aromatic rings, heterocycles, and functional groups typical of this antifungal agent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.